コンテンツへスキップ
Merck

[Familial erythermalgia treated with pizotifen].

Annales de dermatologie et de venereologie (1995-01-01)
M H Guillet, E Le Noach, P Milochau, B Sassolas, G Guillet
要旨

Primary erythermalgia is a rare acrosyndrome due to paroxystic arteriolar dilatation of extremities that become red and congested with warmth and burning sensation or pain. We report herein the observation of a primary erythermalgia affecting 3 degrees in the same family (grandfather, uncle/mother, and children with early onset at 6 years): pizotifene, an antiserotoninergic drug proved to be effective in mother and 14-year-old child who had never drawn benefit from any previous treatment. Several etiologies may be responsible for erythermalgia according to the clinical type: primary erythermalgia with pediatric onset, and secondary erythermalgia as a reaction to myeloproliferation, other diseases, drug or heavy metal poisoning. Pathophysiology of primary erythermalgia is not clearly understood and the main concern is therapy: in this respect, pizotifene deserves to be considered as a valuable possibility.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ピゾチフェン, ≥98% (HPLC)